Incidence and morbidity of cholelithiasi
โ
Michael C. Trendle; Charles G. Moertel; Larry K. Kvols
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 72 KB
๐ 2 views
## Background: Octreotide, a long-acting somatostatin analogue, has demonstrated clinical utility in patients with carcinoid syndrome and malignant islet cell tumors of the pancreas. prior studies have reported a greater than expected incidence of cholelithiasis in patients treated with octreotide